Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.88 USD | -1.40% | +3.45% | -1.69% |
05-02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.69% | 1.36B | |
+31.12% | 49.46B | |
+1.11% | 42.58B | |
+49.00% | 42.49B | |
-5.26% | 29.09B | |
+12.73% | 26.61B | |
-23.76% | 18.64B | |
+7.24% | 13.16B | |
+31.35% | 12.55B | |
+23.77% | 12.1B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- HC Wainwright Adjusts Price Target on Vir Biotechnology to $100 From $125, Keeps Buy Rating